High Risk Patients with COVID-19: Outpatient Management to Prevent Progression
Credit(s): 1.00 (60 min)
11/4/2021 12:00 - 1:00 PM ET
Physicians – AMA PRA Category 1 Credit(s) ™
Patients with COVID-19 have varied risk for increasing severity of disease, with the chance of progression and mortality being higher in older patients and those with comorbidities. Monoclonal antibody therapies that prevent the need for hospitalization in high-risk outpatients who have COVID-19 have been given Emergency Use Authorization by the FDA. These agents include a cocktail consisting of casirivimab and imdevimab and a cocktail of bamlanivimab and etesevimab.
The program High-Risk Patients with COVID-19: Outpatient Management to Prevent Progression will provide clinicians who manage outpatients with COVID-19 with a review of the most current management guidelines and information on the mechanism of action, efficacy and safety data, and patient eligibility for the monoclonal antibodies that have received emergency use authorization (EUA) by the FDA to treat outpatients with COVID-19.
Jointly provided by the Potomac Center for Medical Education and Rockpointe
This program is conducted in collaboration with the National Infusion Center Association.
This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Diabetes and COVID-19 in the Outpatient Setting: What Clinicians Need to Know
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.